메뉴 건너뛰기




Volumn 17, Issue 11, 2008, Pages 3076-3080

Cardiovascular medication use and risk for colorectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 55849093600     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0095     Document Type: Article
Times cited : (55)

References (52)
  • 1
    • 26944473246 scopus 로고    scopus 로고
    • Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
    • Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-27.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1407-1427
    • Edwards, B.K.1    Brown, M.L.2    Wingo, P.A.3
  • 4
    • 36749058297 scopus 로고    scopus 로고
    • When even people at high risk do not take up colorectal cancer screening
    • Ladabaum U. When even people at high risk do not take up colorectal cancer screening. Gut 2007;56:1648-50.
    • (2007) Gut , vol.56 , pp. 1648-1650
    • Ladabaum, U.1
  • 5
    • 35349016919 scopus 로고    scopus 로고
    • Chemoprevention of colorectal cancer
    • Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer. Digestion 2007;76:51-67.
    • (2007) Digestion , vol.76 , pp. 51-67
    • Das, D.1    Arber, N.2    Jankowski, J.A.3
  • 6
    • 34548266731 scopus 로고    scopus 로고
    • Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention
    • Boursi B, Arber N. Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Curr Pharm Des 2007;13:2274-82.
    • (2007) Curr Pharm Des , vol.13 , pp. 2274-2282
    • Boursi, B.1    Arber, N.2
  • 7
    • 33947533150 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the U.S. Preventive Services Task Force
    • Rostom A, Dube C, Lewin G, et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007;146:376-89.
    • (2007) Ann Intern Med , vol.146 , pp. 376-389
    • Rostom, A.1    Dube, C.2    Lewin, G.3
  • 8
    • 10744220122 scopus 로고    scopus 로고
    • Estrogen plus progestin and colorectal cancer in postmenopausal women
    • Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004;350:991-1004.
    • (2004) N Engl J Med , vol.350 , pp. 991-1004
    • Chlebowski, R.T.1    Wactawski-Wende, J.2    Ritenbaugh, C.3
  • 9
    • 0033134701 scopus 로고    scopus 로고
    • Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis
    • Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999;106:574-82.
    • (1999) Am J Med , vol.106 , pp. 574-582
    • Grodstein, F.1    Newcomb, P.A.2    Stampfer, M.J.3
  • 10
    • 0029916051 scopus 로고    scopus 로고
    • Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats
    • Volpert OV, Ward WF, Lingen MW, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996;98:671-9.
    • (1996) J Clin Invest , vol.98 , pp. 671-679
    • Volpert, O.V.1    Ward, W.F.2    Lingen, M.W.3
  • 11
    • 0345700262 scopus 로고    scopus 로고
    • Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists
    • Molteni A, Ward WF, Ts'ao CH, et al. Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists. Curr Pharm Des 2003;9:751-61.
    • (2003) Curr Pharm Des , vol.9 , pp. 751-761
    • Molteni, A.1    Ward, W.F.2    Ts'ao, C.H.3
  • 13
    • 0036239832 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis
    • Wong WW, Dimitroulakos J, Minden MD, Penn LZ. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002;16:508-19.
    • (2002) Leukemia , vol.16 , pp. 508-519
    • Wong, W.W.1    Dimitroulakos, J.2    Minden, M.D.3    Penn, L.Z.4
  • 15
    • 0035498516 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitors and the risk of cancer: A population-based cohort study in Denmark
    • Friis S, Sorensen HT, Mellemkjaer L, et al. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 2001;92:2462-70.
    • (2001) Cancer , vol.92 , pp. 2462-2470
    • Friis, S.1    Sorensen, H.T.2    Mellemkjaer, L.3
  • 17
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • The SOLVD Investigators
    • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
    • (1992) N Engl J Med , vol.327 , pp. 685-691
  • 18
    • 0032543880 scopus 로고    scopus 로고
    • Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
    • Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352: 179-84.
    • (1998) Lancet , vol.352 , pp. 179-184
    • Lever, A.F.1    Hole, D.J.2    Gillis, C.R.3
  • 19
    • 34548019063 scopus 로고    scopus 로고
    • Statins and the risk of colorectal cancer: A meta-analysis of 18 studies involving more than 1.5 million patients
    • Bonovas S, Filioussi K, Flordellis CS, Sitaras NM. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 2007;25:3462-8.
    • (2007) J Clin Oncol , vol.25 , pp. 3462-3468
    • Bonovas, S.1    Filioussi, K.2    Flordellis, C.S.3    Sitaras, N.M.4
  • 20
    • 42249096112 scopus 로고    scopus 로고
    • Statins and cancer: A meta-analysis of case-control studies
    • Taylor ML, Wells BJ, Smolak MJ. Statins and cancer: a meta-analysis of case-control studies. Eur J Cancer Prev 2008;17:259-68.
    • (2008) Eur J Cancer Prev , vol.17 , pp. 259-268
    • Taylor, M.L.1    Wells, B.J.2    Smolak, M.J.3
  • 22
    • 33750627697 scopus 로고    scopus 로고
    • Statins and cancer risk: A literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials
    • Bonovas S, Filioussi K, Tsavaris N, Sitaras NM. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. J Clin Oncol 2006;24:4808-17.
    • (2006) J Clin Oncol , vol.24 , pp. 4808-4817
    • Bonovas, S.1    Filioussi, K.2    Tsavaris, N.3    Sitaras, N.M.4
  • 23
    • 34548096170 scopus 로고    scopus 로고
    • Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: A population-based case-control study
    • Hoffmeister M, Chang-Claude J, Brenner H. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Int J Cancer 2007;121:1325-30.
    • (2007) Int J Cancer , vol.121 , pp. 1325-1330
    • Hoffmeister, M.1    Chang-Claude, J.2    Brenner, H.3
  • 24
    • 19444364509 scopus 로고    scopus 로고
    • Statins and the risk of colorectal cancer
    • Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer. N Engl J Med 2005;352:2184- 92.
    • (2005) N Engl J Med , vol.352 , pp. 2184-2192
    • Poynter, J.N.1    Gruber, S.B.2    Higgins, P.D.3
  • 25
    • 14844292583 scopus 로고    scopus 로고
    • Cancer risk among statin users: A population-based cohort study
    • Friis S, Poulsen AH, Johnsen SP, et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005;114:643-7.
    • (2005) Int J Cancer , vol.114 , pp. 643-647
    • Friis, S.1    Poulsen, A.H.2    Johnsen, S.P.3
  • 26
    • 0034726387 scopus 로고    scopus 로고
    • 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: A nested case-control study
    • Blais L, Desgagne A, LeLorier J. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 2000;160:2363-8.
    • (2000) Arch Intern Med , vol.160 , pp. 2363-2368
    • Blais, L.1    Desgagne, A.2    LeLorier, J.3
  • 29
    • 33846111227 scopus 로고    scopus 로고
    • Statins and the risk of lung, breast, and colorectal cancer in the elderly
    • Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation 2007;115:27-33.
    • (2007) Circulation , vol.115 , pp. 27-33
    • Setoguchi, S.1    Glynn, R.J.2    Avorn, J.3    Mogun, H.4    Schneeweiss, S.5
  • 30
    • 34547499117 scopus 로고    scopus 로고
    • Risk of colorectal cancer in patients prescribed statins, nonsteroidal antiinflammatory drugs, and cyclooxygenase-2 inhibitors: Nested casecontrol study
    • Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF. Risk of colorectal cancer in patients prescribed statins, nonsteroidal antiinflammatory drugs, and cyclooxygenase-2 inhibitors: nested casecontrol study. Gastroenterology 2007;133:393-402.
    • (2007) Gastroenterology , vol.133 , pp. 393-402
    • Vinogradova, Y.1    Hippisley-Cox, J.2    Coupland, C.3    Logan, R.F.4
  • 32
    • 0030600342 scopus 로고    scopus 로고
    • Calcium-channel blockade and incidence of cancer in aged populations
    • Pahor M, Guralnik JM, Ferrucci L, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-7.
    • (1996) Lancet , vol.348 , pp. 493-497
    • Pahor, M.1    Guralnik, J.M.2    Ferrucci, L.3
  • 34
    • 0141563692 scopus 로고    scopus 로고
    • Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years
    • Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer 2003;98:1504-13.
    • (2003) Cancer , vol.98 , pp. 1504-1513
    • Li, C.I.1    Malone, K.E.2    Weiss, N.S.3    Boudreau, D.M.4    Cushing-Haugen, K.L.5    Daling, J.R.6
  • 37
    • 0023759116 scopus 로고
    • Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death
    • Connor J, Sawczuk IS, Benson MC, et al. Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. Prostate 1988;13:119-30.
    • (1988) Prostate , vol.13 , pp. 119-130
    • Connor, J.1    Sawczuk, I.S.2    Benson, M.C.3
  • 38
    • 0027255942 scopus 로고
    • Apoptosis and disease
    • Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993;341:1251-4.
    • (1993) Lancet , vol.341 , pp. 1251-1254
    • Carson, D.A.1    Ribeiro, J.M.2
  • 39
    • 0035254178 scopus 로고    scopus 로고
    • Is diuretic therapy associated with an increased risk of colon cancer?
    • Tenenbaum A, Motro M, Jonas M, et al. Is diuretic therapy associated with an increased risk of colon cancer? Am J Med 2001;110:143-5.
    • (2001) Am J Med , vol.110 , pp. 143-145
    • Tenenbaum, A.1    Motro, M.2    Jonas, M.3
  • 41
    • 3042548409 scopus 로고    scopus 로고
    • Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications
    • Boudreau DM, Doescher MP, Jackson JE, Fishman PA. Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications. Ann Pharmacother 2004;38:1317-8.
    • (2004) Ann Pharmacother , vol.38 , pp. 1317-1318
    • Boudreau, D.M.1    Doescher, M.P.2    Jackson, J.E.3    Fishman, P.A.4
  • 42
    • 3042798873 scopus 로고    scopus 로고
    • A population-based osteoporosis screening program: Who does not participate, and what are the consequences?
    • Buist DS, LaCroix AZ, Brenneman SK, Abbott T. A population-based osteoporosis screening program: who does not participate, and what are the consequences? J Am Geriatr Soc 2004;52:1130-7.
    • (2004) J Am Geriatr Soc , vol.52 , pp. 1130-1137
    • Buist, D.S.1    LaCroix, A.Z.2    Brenneman, S.K.3    Abbott, T.4
  • 43
    • 38449120272 scopus 로고    scopus 로고
    • The association between statins and cancer incidence in a veterans population
    • Farwell WR, Scranton RE, Lawler EV, et al. The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst 2008;100:134-9.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 134-139
    • Farwell, W.R.1    Scranton, R.E.2    Lawler, E.V.3
  • 44
    • 23844508510 scopus 로고    scopus 로고
    • Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention
    • Zielinski SL. Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention. J Natl Cancer Inst 2005;97:1172-3.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1172-1173
    • Zielinski, S.L.1
  • 45
    • 34547670103 scopus 로고    scopus 로고
    • Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
    • Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007;166:348-54.
    • (2007) Am J Epidemiol , vol.166 , pp. 348-354
    • Brookhart, M.A.1    Patrick, A.R.2    Dormuth, C.3
  • 46
    • 1542329169 scopus 로고    scopus 로고
    • Statin use and cancer risk in the General Practice Research Database
    • Kaye JA, Jick H. Statin use and cancer risk in the General Practice Research Database. Br J Cancer 2004;90:635-7.
    • (2004) Br J Cancer , vol.90 , pp. 635-637
    • Kaye, J.A.1    Jick, H.2
  • 48
    • 0032054681 scopus 로고    scopus 로고
    • Calcium channel blockers and the risk of cancer
    • Rosenberg L, Rao RS, Palmer JR, et al. Calcium channel blockers and the risk of cancer. JAMA 1998;279:1000-4.
    • (1998) JAMA , vol.279 , pp. 1000-1004
    • Rosenberg, L.1    Rao, R.S.2    Palmer, J.R.3
  • 49
    • 0028053592 scopus 로고
    • Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells
    • Leszczynski D, Zhao Y, Luokkamaki M, Foegh ML. Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol 1994;145:1265-70.
    • (1994) Am J Pathol , vol.145 , pp. 1265-1270
    • Leszczynski, D.1    Zhao, Y.2    Luokkamaki, M.3    Foegh, M.L.4
  • 50
    • 0028924891 scopus 로고
    • Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: The involvement of intracellular calcium and RNA synthesis
    • Galli C, Meucci O, Scorziello A, Werge TM, Calissano P, Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J Neurosci 1995;15:1172-9.
    • (1995) J Neurosci , vol.15 , pp. 1172-1179
    • Galli, C.1    Meucci, O.2    Scorziello, A.3    Werge, T.M.4    Calissano, P.5    Schettini, G.6
  • 51
    • 0025951117 scopus 로고
    • Verapamil upregulates sensitivity of human colon and breast cancer cells to LAK-cytotoxicity in vitro
    • Correale P, Tagliaferri P, Celio L, Genua G, Montagnani S, Bianco AR. Verapamil upregulates sensitivity of human colon and breast cancer cells to LAK-cytotoxicity in vitro. Eur J Cancer 1991;27:1393-5.
    • (1991) Eur J Cancer , vol.27 , pp. 1393-1395
    • Correale, P.1    Tagliaferri, P.2    Celio, L.3    Genua, G.4    Montagnani, S.5    Bianco, A.R.6
  • 52
    • 0037215258 scopus 로고    scopus 로고
    • Verapamil is associated with an increased risk of cancer in the elderly: The Rotterdam study
    • Beiderbeck-Noll AB, Sturkenboom MC, van der Linden PD, et al. Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer 2003;39:98-105.
    • (2003) Eur J Cancer , vol.39 , pp. 98-105
    • Beiderbeck-Noll, A.B.1    Sturkenboom, M.C.2    van der Linden, P.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.